Core Viewpoint - GE HealthCare Technologies Inc. (GEHC) has introduced Freelium, a next-generation sealed magnet platform aimed at transforming Magnetic Resonance (MR) imaging by using less than 1% of helium compared to traditional systems, thereby enhancing sustainability and accessibility in helium-scarce regions [1][6]. Group 1: Product Features and Benefits - Freelium utilizes intelligent magnet technology that supports AI-enabled solutions, featuring remote monitoring and automated recovery to ensure consistent performance and minimize downtime [2][8]. - The platform is designed to reduce operational costs without compromising performance, operating without additional cooling or power requirements, and includes intelligent sensor technology for remote monitoring [8]. - Freelium's environmentally friendly design aligns with GEHC's sustainability goals, having already saved approximately 3 million liters of helium through its innovative magnet technology [9]. Group 2: Market Impact and Financial Performance - Following the announcement of Freelium, GEHC shares closed flat at $87.35, with a 3% increase over the past six months, compared to the industry’s 7.5% growth and the S&P 500's 8.1% increase during the same period [3]. - The introduction of Freelium is expected to drive long-term stock growth by providing a sustainable and cost-efficient MR imaging solution, potentially increasing GEHC's market share and revenue in the medical imaging sector [4]. - GEHC currently has a market capitalization of $39.95 billion and reported an earnings surprise of 15.1% in the last quarter [5]. Group 3: Strategic Developments - GEHC has made strategic moves to enhance its imaging services and AI capabilities, including a partnership with Sutter Health to improve access to innovative imaging services [10]. - The company is advancing its AI-driven technologies, with recent submissions for FDA clearance and the introduction of new imaging systems aimed at improving diagnostic accuracy and workflow efficiency [11][12].

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium includes access to the Zacks Style Scores as well. What are the Zacks Style Scores? The ...

On Thursday, GE HealthCare GEHC reported fourth-quarter adjusted EPS of $1.45, up from $1.18 a year ago, beating the consensus of $1.26.The company reported sales of $5.32 billion, almost in line with the consensus of $5.33 billion, up 2% on both a reported and organic basis year-over-year. Revenue growth was driven by Advanced Visualization Solutions (AVS) and Pharmaceutical Diagnostics (PDx), with overall strength in the U.S.It clocked 2024 revenues of $19.7 billion, which increased by 1% on both a report ...

GE HealthCare Technologies Inc. (NASDAQ:GEHC) Q4 2024 Earnings Conference Call February 13, 2025 8:30 AM ET Company Participants Carolynne Borders - Chief IR Officer Peter Arduini - President and CEO Jay Saccaro - VP and CFO Conference Call Participants Anthony Petrone - Mizuho Financial Group Craig Bijou - BofA Securities Vijay Kumar - Evercore ISI Matt Taylor - Jefferies Joanne Wuensch - Citi Larry Biegelsen - Wells Fargo David Roman - Goldman Sachs Robbie Marcus - JPMorgan Operator Good day, and thank yo ...

GE HealthCare (GEHC) reported fourth-quarter 2024 adjusted earnings per share (EPS) of $1.45, which beat the Zacks Consensus Estimate of $1.26 by 15.1%. Also, the bottom line improved 22.9% year over year.GAAP EPS in the quarter was $1.57, up 78.4% from the year-ago level.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.Shares of GEHC gained 0.7% during pre-market trading following better-than-expected earnings in the fourth quarter. The company’s shares have gained 3% in the past si ...

Core Insights - GE HealthCare Technologies reported mixed financial results for Q4 2024, with adjusted EPS of $1.45 exceeding expectations of $1.27, while revenue of $5.32 billion showed modest growth of 2% year over year [2][4][7] - The company demonstrated strong earnings performance but highlighted challenges in revenue expansion and cash flow management [3][10] Financial Performance - Adjusted EPS increased by 23% from $1.18 in Q4 2023 to $1.45 in Q4 2024 [4] - Revenue of $5.32 billion was slightly below analysts' expectations of $5.33 billion, reflecting a 2% increase from $5.21 billion in Q4 2023 [4][7] - Net income margin improved to 13.5%, up from 7.7% in the previous year, indicating enhanced profitability [4] - Free cash flow decreased by 15.2% to $811 million from $956 million in Q4 2023, suggesting a need for improved cash management [4][10] Segment Performance - The Pharmaceutical Diagnostics segment experienced significant EBIT growth of 47% year over year, with a 9% revenue increase [8] - Advanced Visualization Solutions segment revenue grew by 4%, while the Imaging segment revenue remained flat year over year, indicating stagnation in a key area [8] Strategic Initiatives - GE HealthCare focused on innovation, launching nearly 40 new products and investing $138 million in Ireland to enhance service capabilities [9] - Partnerships in AI technology, such as with Nuffield Health in the UK, reflect the company's commitment to driving future innovation and market presence [9] Future Outlook - For 2025, GE HealthCare projects organic revenue growth of 2% to 3% and adjusted EPS growth of 3% to 6%, with EBIT margin enhancement to 16.7%-16.8% [12] - The company aims to leverage strategic partnerships and innovation to navigate challenging market conditions, particularly in China [12]

GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.45 per share, beating the Zacks Consensus Estimate of $1.26 per share. This compares to earnings of $1.18 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 15.08%. A quarter ago, it was expected that this medical technology company would post earnings of $1.06 per share when it actually produced earnings of $1.14, delivering a surprise of 7.55%.Over the las ...

GE HealthCare (GEHC) reported better-than-expected fourth-quarter profit on Thursday, while sales were in line with analysts' estimates. The medical device maker reported adjusted earnings per share (EPS) of $1.45 on revenue of $5.32 billion. Analysts polled by Visible Alpha expected $1.26 and $5.32 billion, respectively. GE HealthCare shares, which entered the day up about 3% over the last 12 months, were little changed immediately following the report. The company said it expects year-over-year organic r ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 Commission file number 001-41528 GE HEALTHCARE TECHNOLOGIES INC. (Exact name of registrant as specified in its charter) Delaware 88-2515116 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 500 W. Monroe Street, Chicago, IL 60661 (Address of princip ...

Exhibit 99 GE HealthCare reports fourth quarter and full year 2024 financial results Fourth Quarter 2024 Full Year 2024 Chicago, IL – February 13, 2025 – GE HealthCare (Nasdaq: GEHC) today reported financial results for the fourth quarter and full year ended December 31, 2024. GE HealthCare President and CEO Peter Arduini said, "We were pleased with the strong momentum in orders, backlog and book-to-bill that we saw in the fourth quarter. We also continued to deliver revenue growth driven by demand in our A ...